Engineering LNPs with polysarcosine lipids for mRNA delivery
Since the approval of the lipid nanoparticles (LNP)-mRNA vaccines against the SARS-CoV-2 virus, there has been an increased interest in the delivery of mRNA through LNPs. However, current LNP formulations contain PEG lipids, which can stimulate the generation of anti-PEG antibodies. The presence of...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
KeAi Communications Co., Ltd.
2024-07-01
|
| シリーズ: | Bioactive Materials |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2452199X24000987 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|